75A50325C00019
Definitive Contract
Overview
Government Description
RELENZA (ZANAMIVIR) ROTADISK, 5MG
Awardee
Awarding / Funding Agency
Place of Performance
Durham, NC 27701 United States
Pricing
Fixed Price
Set Aside
None
Extent Competed
Not Competed
Related Opportunity
None
Analysis Notes
Sole Source This Definitive Contract was awarded sole source to Glaxosmithkline because the government believes that only one company can provide the product / service (FAR 6.302-1).
Subcontracting Plan This Definitive Contract has a Commercial Subcontract Plan. The Department of Health and Human Services has an overall small business subcontracting goal of 32%
Subcontracting Plan This Definitive Contract has a Commercial Subcontract Plan. The Department of Health and Human Services has an overall small business subcontracting goal of 32%
Glaxosmithkline was awarded
Definitive Contract 75A50325C00019 (75A503-25-C-00019)
for Relenza (ZANAMIVIR) Rotadisk, 5Mg
worth up to $45,499,950
by the HHS Office of the Assistant Secretary for Preparedness and Response
in September 2025.
The contract
has a duration of 5 years and
was awarded
full & open
with
NAICS 325412 and
PSC 6505
via sole source acquisition procedures with 1 bid received.
As of today, the Definitive Contract has a total reported backlog of $36,399,960.
Status
(Open)
Last Modified 9/26/25
Period of Performance
9/30/25
Start Date
9/29/26
Current End Date
9/29/30
Potential End Date
Obligations and Backlog
$9.1M
Total Obligated
$9.1M
Current Award
$45.5M
Potential Award
$0.0
Funded Backlog
$36.4M
Total Backlog
Award Hierarchy
Definitive Contract
75A50325C00019
Subcontracts
Activity Timeline
People
Suggested agency contacts for 75A50325C00019
Competition
Number of Bidders
1
Solicitation Procedures
Sole Source
Other Than Full and Open Competition
Only One Source - Other
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item
Simplified Procedures for Commercial Items
No
Other Categorizations
Subcontracting Plan
Commercial Subcontract Plan
Cost Accounting Standards
Exempt
Business Size Determination
Large Business
Awardee UEI
FRHTPHMZMX47
Awardee CAGE
667E9
Agency Detail
Awarding Office
75A503 ASPR/ORM-SNS
Funding Office
75A503
Created By
hhslamonica_norwood
Last Modified By
hhskgolden2
Approved By
hhskgolden2
Legislative
Legislative Mandates
None Applicable
Performance District
NC-04
Senators
Thom Tillis
Ted Budd
Ted Budd
Representative
Valerie Foushee
Modified: 9/26/25